Evidence synthesis and pooled analysis of vaccine effectiveness for COVID-19 mRNA vaccine BNT162b2 as a heterologous booster after inactivated SARS-CoV-2 virus vaccines

Introduction of primary COVID-19 vaccination has helped reduce severe disease and death caused by SARS-CoV-2 infection. Understanding the protection conferred by heterologous booster regimens informs alternative vaccination strategies that enable programmatic resilience and can catalyze vaccine conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyaw, Moe H., Spinardi, Julia, Zhang, Ling, Oh, Helen May Lin, Srivastava, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronavirus
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980688/
https://www.ncbi.nlm.nih.gov/pubmed/36727201
http://dx.doi.org/10.1080/21645515.2023.2165856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980688/
https://www.ncbi.nlm.nih.gov/pubmed/36727201
http://dx.doi.org/10.1080/21645515.2023.2165856

Ejemplares similares